Fiche centre
Hospital Universitari Arnau de Vilanova de Lleida
Lleida — Spain
Essais liés3clinical trials
VilleLleidalocalisation
PaysSpainlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07875088
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Coronary Drug-Coated Balloon | Maladie coronarienne | À vérifier | NCT07875088 | RW-DCB — Real-World Outcomes of Drug-Coated Balloon Angioplasty in Coronary Artery Disease | NOT_YET_RECRUITING |
| Ocrelizumab | SEP | Phase 3 | NCT03599245 | This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS) | COMPLETED |
| Fenebrutinib | SEP | Phase 3 | NCT04544449 | FENtrepid — A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis | ACTIVE_NOT_RECRUITING |